← Eichor
Condition: Nephronophthisis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nephronophthisis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NA · 1 location(s) · Imagine Institute · NCT06648044M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid
Phase 1 · 5 location(s) · EMD Serono Research & Development Institute, Inc. · NCT07166601ARPKD Database Study
Phase N/A · 6 location(s) · Children's Hospital of Philadelphia · NCT01401998Antigen-specific T Cells Against Lung Cancer
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03356808National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Intervention of CAR-T Against Cervical Cancer
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03356795
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.